Nitin Lifesciences

Pharmaceutical company with a strong presence in injectable manufacturing.

Launch date

1994

Employees

Market cap

Enterprise valuation

CAD136m (Public information from Oct 2015)

India (HQ)

Date	Investors	Amount	Round
Oct 2015	Recipharm	SEK824m Valuation: SEK824m	Acquisition
Dec 2023*	Synokem Pharmaceuticals	N/A	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Nitin Lifesciences